¥¹¥Æ¡¼¥­¤Ï¤è¤¯¾Æ¤¤¤¿¤â¤Î¤ò¹¥¤à¿Í¤â¿¤¤¤¬¡¢¾Ç¤²ÌܤΤĤ¤¤¿Æù¤ò¿©¤Ù¤ë¤Èç¹´â¥ê¥¹¥¯¤¬ÁýÂ礹¤ë²ÄǽÀ­¤Î¤¢¤ë¤³¤È¤¬¡¢¿·¤·¤¤¸¦µæ¤Ç¼¨¤µ¤ì¤¿¡£

º£²ó¤Î¸¦µæ¤Ç¤Ï¡¢Á°Î©Á£¡¢ÇÙ¡¢·ëIJľIJ¡¢ÍñÁã(PLCO)¿»ÜÀߥ¹¥¯¥ê¡¼¥Ë¥ó¥°»î¸³¤Î»²²Ã¼ÔÌó6Ëü3,000¿Í¤òÂоݤȤ·¤¿Æù¤ÎÀݼ衢ĴÍýË¡¤ä¾Æ¤­²Ã¸º¤Î¹¥¤ß¤Ë´Ø¤¹¤ë¥Ç¡¼¥¿¤ò»ÈÍÑ¡£9ǯ´Ö¤Ë208¿Í¤¬ç¹´â¤òȯ¾É¤·¤¿¡£¤è¤¯¾Æ¤¤¤¿(well done)¥¹¥Æ¡¼¥­¤ò¹¥¤à¿Í¤Ï¡¢¤¢¤Þ¤ê¾Æ¤¤¤Æ¤¤¤Ê¤¤¥¹¥Æ¡¼¥­¤ò¹¥¤à¿Í¤ä¥¹¥Æ¡¼¥­¤ò¿©¤Ù¤Ê¤¤¿Í¤ËÈæ¤Ù¤Æç¹´â¤Ë¤Ê¤ëÈæΨ¤¬60%¹â¤«¤Ã¤¿¡£¤µ¤é¤Ë¡¢Æù¤ÎÁíÀݼèÎ̤ª¤è¤Ó¾Æ¤­²Ã¸º¤Î¹¥¤ß¤Ë´ð¤Å¤¤¤Æȯ´âʪ¼Á¤ÎÀݼèÎ̤ò¿äÄꤷ¤¿·ë²Ì¡¢ºÇ¤âÀݼèÎ̤¬¹â¤¤·²¤Ï¡¢ºÇ¤âÄ㤤·²¤ËÈæ¤Ù¤Æç¹´â¥ê¥¹¥¯¤¬70%¹â¤«¤Ã¤¿¤È¤¤¤¦¡£

Æù¤ò¾Ç¤²¤ë¤Þ¤Çß֤᤿¤ê¡¢¥°¥ê¥ë¤ä¥Ð¡¼¥Ù¥­¥å¡¼¤Ç¾Æ¤¤¤¿¤ê¤¹¤ë¤È¡¢¥ª¡¼¥Ö¥óÎÁÍý¤ä¼Ñ¹þ¤ßÎÁÍý¤Ç¤ÏÀ¸À®¤·¤Ê¤¤È¯´âʪ¼Á¤¬¤Ç¤­¤ë¤³¤È¤¬¤¢¤ë¤È¡¢¸¦µæ¤ò¹Ô¤Ã¤¿Êƥߥͥ½¥¿Âç³Ø¸ø½°±ÒÀ¸³ØÉô(¥ß¥Í¥¢¥Ý¥ê¥¹)½Ú¶µ¼ø¤ÎKristin Anderson»á¤ÏÀâÌÀ¤·¤Æ¤¤¤ë¡£º£²ó¤Î¸¦µæ¤Ï¡¢Êƥǥó¥Ð¡¼¤Ç³«ºÅ¤µ¤ì¤¿Êƹñ´â³Ø²ñ(AACR)ǯ¼¡½¸²ñ¤Çȯɽ¤µ¤ì¤¿¡£

A nderson»á¤Ï¡¢Æù¤òÄ´Íý¤¹¤ëºÝ¤Ë¤Ï¡¢ºÙ¶Ý¤¬»àÌǤ¹¤ë¤è¤¦¤Ë¤è¤¯²Ð¤òÄ̤¹¤Ù¤­¤À¤¬¡¢¾Ç¤²¤µ¤»¤Ê¤¤¤è¤¦¤Ë¤È´«¤á¤Æ¤¤¤ë¡£¤Þ¤¿¡¢Æù¤ò¥°¥ê¥ë¤Ç¾Æ¤¯Á°¤ËÅŻҥì¥ó¥¸¤Ç¿ôʬ´Ö²áÇ®¤·¤ÆÆù½Á¤òÍî¤È¤¹¤È¡¢È¯´âʪ¼Á¤ÎÁ°¶îʪ¼Á¤ò¸º¤é¤¹¤³¤È¤¬¤Ç¤­¤ë¤È¤¤¤¦¡£¡Ö¾Ç¤²¤¿Æù¤ËÀ¸¤¸¤ëȯ´âʪ¼Á¤Ë¤è¤Ã¤Æ¥ê¥¹¥¯¤¬ÁýÂ礹¤ë¤È¤ÏÃǸÀ¤Ç¤­¤Ê¤¤¤¬¡¢Æù¤òÄ´Íý¤¹¤ë¤È¤­¤Ï²Ð¤ò¼å¤¯¤¹¤ë¤«¡¢¾Ç¤²¤¿Éôʬ¤òÀÚ¤êÍî¤È¤¹¤Û¤¦¤¬¤è¤¤¡×¤ÈƱ»á¤Ï½Ò¤Ù¤Æ¤¤¤ë¡£
(¾Ç¤²¤¿Æù¤Ïç¹´â¥ê¥¹¥¯¤òÁýÂ礵¤»¤ë)


ç¹´â¤Ï¡¢ç¹Â¡¤«¤éȯÀ¸¤·¤¿°­À­¼ðáç(¾åÈéÀ­°­À­¼ðáç)¤Ç¤¹¡£¿Ê¹Ô¤¬Á᤯¡¢¤­¤ï¤á¤Æͽ¸å¤¬°­¤¤¤È¤µ¤ì¤Æ¤¤¤Þ¤¹¡£È¯À¸Î¨¤ÏÌó1,000¿Í¤Ë1¿Í¤Ç¡¢60¡Á70ºÐÂå¤Î¹âÎð¼Ô¤Ë¿¤¯¡¢Áý²Ã·¹¸þ¤Ë¤¢¤ë¤È¤¤¤ï¤ì¤Æ¤¤¤Þ¤¹¡£

ç¹Â¡¤Ïç¹±Õ¤ò»ºÀ¸¤¹¤ëÁ£Ë¼¡¢ç¹±Õ¤ò±¿¤Öç¹´É¡¢¤ª¤è¤ÓÆâʬÈçÁ£¤Ç¤¢¤ë¥é¥ó¥²¥ë¥Ï¥ó¥¹Åç¤Ê¤É¤«¤é¤Ê¤ê¤Þ¤¹¤¬¡¢ç¹´â¤ÎÌó90%¤Ï繴ɤ«¤éȯÀ¸¤¹¤ëç¹´É´â¡Êductal cell carcinoma¡Ë¤Ç¡¢Ä̾ï¡Öç¹´â¡×¤È¤¤¤¨¤Ðç¹´É´â¤ò»Ø¤·¤Þ¤¹¡£

ȯÀ¸Éô°Ì¤Ë¤è¤ê¡¢ç¹´â¤Ï
­¡ç¹Æ¬Éô´â
­¢ç¹ÂÎÉô´â
­£ç¹ÈøÉô´â(­¢­£¤ò¹ç¤ï¤»¤Æç¹ÂÎÈøÉô´â)
­¤ç¹Á´Âδâ
¤ËʬÎव¤ì¤Þ¤¹¡£ç¹Â¡¤ÎÃæ¤Ç¤â¡¢ç¹Æ¬Éô´â¤¬Ìó2/3¤Ç¿¤¯¡¢¼þ°ÏÁÈ¿¥¤Ø¿»½á¤·¤Æ¤¤¤­¤Þ¤¹¡£¸«¤Ä¤«¤ê¤Ë¤¯¤¯(¸¡¿Ç¤Ê¤É¤Ç¤ÏÉáÄÌ¡¢¤¢¤Þ¤êç¹Â¡´â¤òµ¿¤Ã¤Æ¸¡ºº¤ò¤¹¤ë¡¢¤È¤¤¤¦¤³¤È¤â¾¯¤Ê¤¤¤¿¤á)¡¢¿ÇÃÇ»þ¤Ë¤Ï¤Û¤È¤ó¤É¤¬¿Ê¹Ô´â¤Ç¤¹¡£

½éȯ¾É¾õ¤È¤·¤Æ¤Ï̵ÄËÀ­¤Î²«áÕ¤¬Â¿¤¯¡¢ÈéÉ沫À÷¤È¤È¤â¤Ë±¦¾åÊ¢Éô¤ËÃÀǹ¤ò¿¨ÃΤ·¤Þ¤¹¡£´ðËÜŪ¤Ë¡¢²«áդϷìÃæ¤Î¥Ó¥ê¥ë¥Ó¥óÇ»ÅÙ¤¬2¡Á3 mg/dL¤òĶ¤¨¤ëÄøÅ٤ˤʤë¤Èµ¤¤Å¤«¤ì¤ë¤è¤¦¤Ë¤Ê¤ê¤Þ¤¹¡£²«áդǤϡ¢²«¿§Ä´¤ÎÇòÌܤäÈéÉæ¤ÈƱ»þ¤Ë³ì¿§Ç¢¤òÁʤ¨¡¢´µ¼Ô¤µ¤ó¤Ë¤è¤Ã¤Æ¤ÏÇ¢¤Î¿§¤ÎÊѲ½¤ò¼çÁʤËÍ象¤¹¤ë¤³¤È¤â¤¢¤ê¤Þ¤¹¡£ÈéÉæ¤ÎáڤߤòÁʤ¨¤ë¾ì¹ç¤â¤¢¤ê¡¢²«áդνÅÍפÊħ¸õ¤Î1¤Ä¤È¤Ê¤Ã¤Æ¤¤¤Þ¤¹¡£

¾¤Ë¤â¡¢Ê¢ÄË¡¢ÂνŸº¾¯¡¢²«áÕ¡¢ÂÑÅüǽ°Û¾ï¤Ê¤É¤¬¤¢¤ê¤Þ¤¹¤¬¡¢½é´ü¤Ë¤Ï̵¾É¾õ¤Î¤³¤È¤¬Â¿¤¤¤¿¤á¡¢È¯¸«¤¬ÃÙ¤ì¤ä¤¹¤¤¤È¤µ¤ì¤Æ¤¤¤Þ¤¹¡£¿Ê¹Ô´â¤Ë¤Ê¤ë¤ÈÇØÉôÄË¡¢Ê¢ÄË¡¢²¼Î¡¤¬½Ð¸½¤·¤Þ¤¹¡£Ãæ¤Ç¤â¡¢ç¹Â¡¤Î¾ã³²¤Ë¤è¤ë2ǯ°ÊÆâ¤ÎÅüÇ¢ÉÂȯ¾É¡¢µÞ·ã¤ÊÂνŸº¾¯¤ÏÍ­ÎϤʿÇÃǤμê³Ý¤«¤ê¤È¤Ê¤ê¤Þ¤¹¡£

¸¶°ø¤ÏÌÀ¤é¤«¤Ç¤¢¤ê¤Þ¤»¤ó¤¬¡¢³°Éô´Ä¶­°ø»Ò¤È¤·¤ÆµÊ±ì¡¢¿©½¬´·¡¢°û¼ò¡¢»º¶È´ØϢȯ´âʪ¼Á¤Ê¤É¤È¤Î´Ø·¸¤¬¼¨º¶¤µ¤ì¤Æ¤¤¤Þ¤¹¡£Æäˡ¢ÆüËܤǤÏÆùÎàÀݼè¤Ëȼ¤¦¹â»éËÿ©¤ª¤è¤ÓµÊ±ì¤È¤Î´ØÏ¢¤¬»ØŦ¤µ¤ì¤Æ¤¤¤Þ¤¹¡£

ÆâÉô´Ä¶­°ø»Ò¤È¤·¤Æ¤Ï¡¢½¾Íè¤Ç¤ÏÅüǢɡ¢ËýÀ­ç¹±ê¤Ê¤¤¤·ç¹Àоɡ¢ÃÀÆ»¼À´µ¤Ê¤É¤È¤Î´ØÏ¢¤¬ÃíÌܤµ¤ì¤Æ¤ª¤ê¤Þ¤¹¤¬¡¢ÌÀ¤é¤«¤Ê°ø²Ì´Ø·¸¤Ï¤Ê¤ªÎ©¾Ú¤µ¤ì¤Æ¤Ï¤ª¤ê¤Þ¤»¤ó¡£

¼£ÎŤȤ·¤Æ¤Ï¡¢°Ê²¼¤Î¤è¤¦¤Ê¤â¤Î¤¬¤¢¤ê¤Þ¤¹¡£
ç¹Æ¬Éô´â¤ËÂФ·¤Æ¤Ï¡¢°ìÈÌŪ¤ËÂè2·²¤Î¥ê¥ó¥ÑÀá³ÔÀ¶¤òȼ¤¦ç¹ÀÚ½ü½Ñ¤¬¹Ô¤ï¤ì¤Þ¤¹¡£¤µ¤é¤Ë¡¢¸åÊ¢Ë졦ÂçÆ°Ì®¼þ°Ï¥ê¥ó¥ÑÀá¤ä¿À·ÐÁѤι­ÈϰϳÔÀ¶¤òȼ¤¦³ÈÂç³ÔÀ¶¤Î¼ê½Ñ¤â¹Ô¤ï¤ì¤Þ¤¹¡£ç¹ÂÎÈøÉô´â¤ËÂФ·¤Æ¤Ï±ó³Öž°Ü¡¢¹âÅÙ¥ê¥ó¥ÑÀáž°Ü¡¢¼þ°Ï·ì´É¿»½á¤¬¤Ê¤±¤ì¤Ð¡¢ç¹ÂÎÈøÉôç£ÀÚ½ü½Ñ¤ò¹Ô¤¤¤Þ¤¹¡£

²½³ØÎÅË¡¤È¤·¤Æ¤Ï¡¢ç¹´â¤ËÂФ·¤Æ³Î¼Â¤Ë¼£ÎŸú²Ì¤ò¼¨¤¹¹³´âºÞ¤Ïº£¤Î¤È¤³¤í¤Ê¤¤¤È¤¤¤ï¤ì¤Æ¤¤¤Þ¤¹¡£¤Ç¤¹¤¬¡¢Low dose FPÎÅË¡(5-FU+ÄãÍÑÎÌCDDP)¤ä¡¢Gemcitabine(¾¦ÉÊ̾¡§¥¸¥§¥à¥¶¡¼¥ë¡Ë¤ò´ðËÜÌôºÞ¤È¤·¤Æ¡¢GEM¡Ü£µ-FU¡¢GEM¡Üepirubicin¡¢GEM¡ÜCDDP¡¢GEM¡ÜTS£±¤ÎÊ»ÍÑÎÅË¡¤¬¹Ô¤ï¤ì¡¢Èæ³ÓŪ¹â¤¤ÁÕ¸úΨ¤¬Êó¹ð¤µ¤ì¤Æ¤¤¤Þ¤¹¡£

¤Þ¤¿¡¢Êü¼ÍÀþÎÅË¡¤¬¹Ô¤ï¤ì¤ë¤³¤È¤â¤¢¤ê¡¢½ÑÃæ¾È¼Í¡¢½Ñ¸å¤ÎÂγ°¾È¼Í¤Ê¤É¹ç·×50¥°¥ì¥¤¤ò¾È¼Í¤·¤Þ¤¹¡£ºÇ¶á¤Ï¾¯Î̤β½³ØÎÅË¡¤È¤¢¤ï¤»¤¿Êü¼ÍÀþ²½³ØÎÅË¡¤¬¹­¤¯¹Ô¤ï¤ì¤Æ¤¤¤Þ¤¹¡£

¤¿¤À¡¢¼£ÎÅÀ®ÀÓ¤ÏÉÔÎɤǤ¢¤ë¤È¤¤¤ï¤¶¤ë¤ò¤¨¤Ê¤¤¤Ç¤·¤ç¤¦¡£º¬¼£Åª¼£ÎŤȤ·¤Æ¼ê½Ñ¤¬¹Ô¤ï¤ì¤Þ¤¹¤¬¡¢ÀÚ½üΨ¤¬20¡Á40¡ó¤ÈÄ㤯¡¢ÀÚ½ü¤Ç¤­¤Æ¤â5ǯÀ¸Â¸Î¨¤Ï10¡Á15¡óÄøÅ٤ˤȤɤޤë¤È¤¤¤ï¤ì¤Æ¤¤¤Þ¤¹¡£

¾åµ­¤Î¸¦µæ¤¬¡¢²Ì¤¿¤·¤ÆËÜÅö¤ËÀµ¤·¤¤¤Î¤«¤É¤¦¤«¤Ïʬ¤«¤ê¤Þ¤»¤ó¤¬¡¢Æü¾ï¤Ç¤Á¤ç¤Ã¤È¤·¤¿Ãí°Õ¤ò¹Ô¤¨¤ÐÎɤ¤¤À¤±¤Ç¤¹¤Î¤Ç¡¢¤Ç¤­¤ë¤À¤±¿©¤Ù¤Ê¤¤¤è¤¦¤Ë¹©Éפµ¤ì¤Æ¤Ï¤¤¤«¤¬¤Ç¤·¤ç¤¦¤«¡£

¡Ú´ØÏ¢µ­»ö¡Û
ç¹´â¤È¤ÎÆ®ÉÂÀ¸³è¤ò¸ì¤ë¡Ýºî²È¡¦·ªËÜ·°¤µ¤ó

¤³¤Î40ǯ¤Ç10ÇܤËÁý¤¨¤¿ç¹Â¡¥¬¥ó